A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

During a live event, Ahmad Tarhini, MD, PhD, discussed key melanoma trials with varying survival and toxicity profiles.

No more IV drips, cancer patients on immunotherapy can now take the drug in a single injection. The National Health Service ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

The United Kingdom's National Health Services, the NHS, have rolled out a super jab that can treat up to 15 types of cancers, ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

The NHS is set to roll out a a new five-minute ‘super-jab’ that can treat 15 types of cancer and will ‘transform lives’.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Bristol Myers Squibb’s (NYSE: BMY) Opdivo ...

A groundbreaking five-minute "super-jab" is poised to benefit thousands of cancer patients in England, with the potential to ...

This innovative rollout makes England the first country in Europe to adopt the approach at scale. NHS officials expect the treatment to be made available to around 1,200 eligible patients per month.

The NHS is launching a revolutionary five-minute 'super-jab' capable of treating 15 types of cancer, potentially saving ...

Following approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), clinical trials showed high ...